Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
GSK PLC
GSK
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.

























| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$612+7.6% +4.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | GSK PLC GSK | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Good buy·+$2.7K+34.1% +22.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | GSK PLC GSK | Nov 18, 2024 298 days to disclose · 253 past 45-day window | Good buy·+$4K+50.0% +45.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 10, 2025 8mo ago | ![]() Robert B. Aderholt RHouseAlabama-04 | ↓sold | GSK PLC GSK | Jul 28, 2025 44 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$2.2K+27.2% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | GSK PLC GSK | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | GSK PLC GSK | Mar 3, 2025 44 days to disclose | Good buy·+$2.7K+33.1% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | GSK PLC GSK | Nov 25, 2024 2 days to disclose | Good buy·+$3.8K+48.0% +45.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 4, 2024 1.7y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | GSK PLC GSK | Sep 3, 2024 1 day to disclose | Good buy·+$2K+25.3% −4.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.6y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.9K-48.8% +14.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↓sold | GSK PLC GSK | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 12, 2023 3.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 39 days to disclose | Good buy·+$4.1K+51.4% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 11, 2023 3.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↑bought | GSK PLC GSK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 38 days to disclose | Good buy·+$4.1K+51.4% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 4, 2023 3.2y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↓sold | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Mar 1, 2023 34 days to disclose | Flat·+0.0% +80.8% vs S&P 500 | $50K-$100K midpoint $75K |
Sep 8, 2022 3.7y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 16, 2022 23 days to disclose | Good buy·+$4.4K+54.9% −11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 8, 2022 3.7y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 10, 2022 29 days to disclose | Good buy·+$13.9K+42.6% −27.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 8, 2022 3.7y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 9, 2022 30 days to disclose | Good buy·+$2.9K+36.5% −37.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 8, 2022 3.7y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 5, 2022 34 days to disclose | Good buy·+$11.3K+34.7% −38.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 5, 2022 3.8y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↓sold | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 12, 2022 24 days to disclose | Flat·+0.0% +87.4% vs S&P 500 | $100K-$250K midpoint $175K |
Aug 5, 2022 3.8y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK JT GSK plc American Depositary Shares ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 6, 2022 30 days to disclose | Good buy·+$2.1K+26.7% −59.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 4, 2022 4.1y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | GSK PLC GSK GlaxoSmithKline PLC ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Apr 11, 2022 23 days to disclose | Good buy·+$5.7K+17.5% −44.7% vs S&P 500 | $15K-$50K midpoint $32.5K |